Cancer BiologybioRxiv
Co-inhibition of BCL-XL and MCL-1 with BCL-2 selective inhibitors A1331852 and S63845 enhances cytotoxicity of cervical cancer cell lines
S. F. Abdul Rahman, K. Muniandy, Y. K. Soo…·N. Mohana Kumaran
This study shows that combining BCL-XL and MCL-1 inhibitors A1331852 and S63845 significantly enhances cytotoxicity in cervical cancer cell lines compared to single-agent treatments.
DOI 10.1016/j.bbrep.2020.100756